SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

IN THE PRESS
Press Releases
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
December 5, 2024
 · 
3 min read
Press Releases
CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
November 25, 2024
 · 
7 min read
Press Releases
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
November 18, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 15, 2024
 · 
6 min read
Press Releases
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 5, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 4, 2024
 · 
2 min read
Press Releases
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 24, 2024
 · 
4 min read
Press Releases
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
October 10, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
 · 
2 min read
Load More
JOBS